Product Name | MF | CAS | Details |
---|
Doxepin hydrochloride | C19H22ClNO | 1229-29-4 | Details |
Dibenzofuran | C12H8O | 132-64-9 | Details |
3-O-(2-Acetamido-2-deoxy-b-D-glucopyranosyl)-D-galactose | C14H25NO11 | 67006-44-4 | Details |
3-Fluoro-4-nitroanisole | C7H6FNO3 | 446-38-8 | Details |
1-Cyano-N-[(4-fluorophenyl)methyl]methanesulfonamide | C9H9FN2O2S | 948910-03-0 | Details |
6-Azaspiro[3.4]octane-2,5-dione | C7H9NO2 | 2091102-07-5 | Details |
3'-Deoxyuridine | C9H12N2O5 | 7057-27-4 | Details |
5-(Bromomethyl)-1H-1,3-benzodiazole hydrobromide | C8H8Br2N2 | 1357946-12-3 | Details |
Renzapride hydrochloride | C16H23Cl2N3O2 | 109872-41-5 | Details |
R 112 | C16H13FN4O2 | 575474-82-7 | Details |
A 127722 | C29H38N2O6 | 195704-72-4 | Details |
VDAC1 antibody | Details |
1-Chloro-4-iodo-2,5-dimethylbenzene | C8H8ClI | 854861-39-5 | Details |
DBCO-dPEG?24-TFP Ester | Details |
4-Benzylphenylboronic acid pinacol ester | C19H23BO2 | 911708-01-5 | Details |
B7H1 antibody (biotin) | Details |
NGD 4715 | C19H24BrN3O3 | 476322-70-0 | Details |
(6-Fluoro-1,3-benzoxazol-2-yl)methanol | C8H6FNO2 | 1394041-04-3 | Details |
Boc-S-benzyl-D-cysteine | C15H21NO4S | 102830-49-9 | Details |
2,5-Dichlorophenylthioglycolic Acid | C8H6Cl2O2S | 6274-27-7 | Details |
3-Amino-5-fluoropyridin-2-ol | C5H5FN2O | 1257069-38-7 | Details |
4-Cyclopentylbutan-2-one | C9H16O | 18216-75-6 | Details |
5-Vinylbicyclo[2.2.1]hept-2-ene - stabilized with BHT | C9H12 | 3048-64-4 | Details |
Benzyl 4-(2-ethoxy-2-oxoethylidene)piperidine-1-carboxylate | C17H21NO4 | 82244-11-9 | Details |
Sarafloxacin | C20H17F2N3O3 | 98105-99-8 | Details |
NPHP4 antibody | Details |
2-Pyrrolidin-1-yl-propylamine | C7H16N2 | 50998-07-7 | Details |
1-Chlorobutan-2-ol | C4H9ClO | 1873-25-2 | Details |
N-(2-Azidoethyl)-2-(tert-butylsulfanyl)acetamide | C8H16N4OS | 1249892-46-3 | Details |
Ier3ip1 antibody | Details |
1-(3,4-dichlorophenyl)-2,6,6-trimethyl-5,6,7-trihydroindol-4-one | C17H17Cl2NO | 627836-40-2 | Details |
Camphor | C10H16O | 76-22-2 | Details |
1,2,3-Phenenyl triacetate | C12H12O6 | 525-52-0 | Details |
(3S)-3-(Boc-amino)-3-methylpyrrolidine | C10H20N2O2 | 927652-04-8 | Details |
4-(2-Methyl-1,3-dioxolan-2-yl)piperidine | C9H17NO2 | 94626-55-8 | Details |
Benzyl 7-oxo-2,6-diazaspiro-[4.5]decane-2-carboxylate | C16H20N2O3 | 1160246-74-1 | Details |
UUU-GGFL-OH | Details |
Minocycline HCL | C23H27N3O7 | Details |
N-1,3-Benzothiazol-2-yl-2-chloropropanamide | C10H9ClN2OS | 26608-39-9 | Details |
2-(Cyclopropylcarbonyl)indane-1,3-dione | C13H10O3 | 6286-26-6 | Details |
2-{Cyclopropyl[(9H-fluoren-9-ylmethoxy)carbonyl]amino}acetic acid | C20H19NO4 | 1342767-08-1 | Details |
2,3-Dihydro-1-benzothiophene-2-carboxylic acid | C9H8O2S | 27916-82-1 | Details |
(1H-1,2,3,4-Tetrazol-5-yl)urea | C2H4N6O | 6973-21-3 | Details |
4-Amino-2-chloro-N,N-dimethylbenzamide | C9H11ClN2O | 98995-06-3 | Details |
tert-Butyl (3S,5S)-3-amino-5-fluoropiperidine-1-carboxylate | C10H19FN2O2 | 1932056-72-8 | Details |
Cardiolipin/Beta-2-glycoprotein-1 Antibody Positive Human Plasma | Details |
TAMRA-OO-CTG ACC GTC CCA GGT | Details |
4-Cyclopropyl-5,6-difluoro-1,2,3,4-tetrahydroquinoxalin-2-one | C11H10F2N2O | 1461715-71-8 | Details |
3-(2-Aminoethyl)-5-[(4-methylphenyl)methylidene]-1,3-thiazolidine-2,4-dione hydrochloride | C13H15ClN2O2S | 1093344-89-8 | Details |
LH ELISA kit | Details |
3,4:5,6-Di-O-Isopropylidene-7-deoxy-D- glycero- L- gulo- heptitol | Details |
1-[3-(Aminomethyl)pyrrolidin-1-yl]-2-methylpropan-2-ol | C9H20N2O | 1250984-97-4 | Details |
2,5-Dimethoxybenzenesulfonyl chloride | C8H9ClO4S | 1483-28-9 | Details |
HAVCR2 antibody | Details |
Methyl N-trifluoroacetyldaunosaminide | C9H14F3NO4 | 51996-41-9 | Details |
2-(Morpholin-4-yl)acetyl chloride hydrochloride | C6H11Cl2NO2 | 167982-24-3 | Details |
2-(5-Hydroxybenzo[D]isoxazol-3-yl)acetic Acid | C9H7NO4 | 34173-03-0 | Details |
4-(4-Methylpentyl)cyclohexan-1-one | 14370-90-2 | Details |
Colloidal Chitin | C6H11NO4X2 | 1398-61-4 | Details |
2-Bromo-8λ?-thiabicyclo[3.2.1]octane-3,8,8-trione | C7H9BrO3S | 2126176-82-5 | Details |
2-Methyl-6-(pyrrolidin-1-yl)pyridine-4-carbonitrile | C11H13N3 | 1601948-35-9 | Details |
4-(4,5-Dimethyl-1H-imidazol-1-yl)benzaldehyde | C12H12N2O | 117606-93-6 | Details |
4-Bromo-3-chloro-5-methylbenzoic acid | C8H6BrClO2 | 1416352-15-2 | Details |
Ethyl 3-((3-bromophenyl)amino)-5-methyl-2,4-thiazolecarboxylate | C13H13BrN2O2S | 1797685-21-2 | Details |
Nolatrexed dihydrochloride | C14H14Cl2N4OS | 152946-68-4 | Details |
5-Methoxy-1H-indole-2-carbaldehyde | C10H9NO2 | 21778-81-4 | Details |
Weak Acid Yellow 3G | C39H3608N8S3Na2Cl4 | 151439-57-5 | Details |
4-(2H-[1,2,4]Triazol-3-yl)-benzoic acid | C9H7N3O2 | 876715-40-1 | Details |
Cannabidiol dimethyl ether | C23H34O2 | 1242-67-7 | Details |
SCPB | C52H80N14O11S2 | 84746-43-0 | Details |
KIFC2 antibody | Details |
4-(2-fluorophenyl)piperazinyl 3-(1,1,2,2-tetrafluoroethoxy)phenyl ketone | C19H17F5N2O2 | 1023803-86-2 | Details |
3,3-Dimethyl-1-pyrrolidin-1-ylbutan-2-amine | C10H22N2 | 844882-19-5 | Details |
2-[(5-Bromo-2,3-dihydro-1H-inden-1-yl)amino]ethan-1-ol | C11H14BrNO | 1247396-97-9 | Details |
2-[4-(Methoxymethyl)phenyl]acetonitrile | C10H11NO | 111735-59-2 | Details |
2-Sulfanylideneimidazolidine-1-carbaldehyde | C4H6N2OS | 954379-26-1 | Details |
RhoB protein (His tag) | Details |
4-Methyl-5-(trifluoromethyl)pyridin-2-ol | C7H6F3NO | 1590412-13-7 | Details |
3-[(4-Chlorophenyl)sulfanyl]-2-nitrobenzoic acid | C13H8ClNO4S | 1546589-07-4 | Details |
Cyclopentyl(3-fluorophenyl)methanamine | C12H16FN | 1183979-95-4 | Details |
2,4-Dichloro-5-(propan-2-yl)pyrimidine | C7H8Cl2N2 | 514843-12-0 | Details |
6-Cyanoimidazo[1,2-a]pyridine-3-carboxylic acid | C9H5N3O2 | 1019021-71-6 | Details |
C-Furan-2-yl-C-phenyl-methylaminehydrochloride | C11H12ClNO | 53387-67-0 | Details |
Anti-ACE2 antibody - 0.21mg/mL | Details |
6-(Pyrrolidin-1-yl)-9H-purine | C9H11N5 | 1928-89-8 | Details |
4-Bromo-1,2-thiazole-5-sulfonyl chloride | C3HBrClNO2S2 | 1781557-85-4 | Details |
Methyl 5-[(piperidin-2-yl)methyl]-1,2-oxazole-3-carboxylate hydrochloride | 2193061-76-4 | Details |
5-Bromo-5-nitro-1,3-dioxane (solution) | Details |
Eichlerianic acid | C30H50O4 | 56421-13-7 | Details |
Methyl 3-bromo-6-fluoropyridine-2-carboxylate | C7H5BrFNO2 | 1214324-98-7 | Details |
1-Cyclobutylpentan-1-amine | C9H19N | 1270489-69-4 | Details |
Valsartan-d3 | C24H26D3N5O3 | 1331908-02-1 | Details |
5-Chloro-2-(2-methanesulfonylethoxy)aniline | C9H12ClNO3S | 1179912-90-3 | Details |
N-(4-Amino-2,6-dichlorophenyl)pyridine-4-carboxamide | C12H9Cl2N3O | 926241-26-1 | Details |
(1R)-1-(3-Bromo-4-methoxyphenyl)-2,2,2-trifluoroethan-1-ol | C9H8BrF3O2 | 1461689-27-9 | Details |
Osteostatin amide trifluoroacetate | C142H229N43O57 | 204383-55-1 | Details |
Ethyl 2-amino-5-(difluoromethyl)thiazole-4-carboxylate | C7H8F2N2O2S | 1710293-58-5 | Details |
Desmin Blocking Peptide | Details |
1-Ethynyl-2-azabicyclo[2.1.1]hexane hydrochloride | C7H10ClN | 2126160-91-4 | Details |
H-PLKAEIAQRLEDV-OH | Details |
Product Total: Product Page: | ||||
41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 |